WOMEN, WEIGHT-LOSS MEDICATION & THE MUSCLE QUESTION

Why losing weight is only half the story

By Wellvia | Precision Health & Personalised Wellness

Weight-loss medications have changed the conversation around obesity, appetite and metabolic health. Treatments such as semaglutide and tirzepatide can help eligible individuals achieve meaningful weight loss, often by reducing hunger and increasing feelings of fullness.

For many women, this can be an important step towards improving health. But the number on the scales does not tell the whole story.

What happens to muscle? Is nutritional intake still adequate when appetite falls? What should happen to training during menstruation, perimenopause or menopause? And how do we make sure that weight lost translates into better long-term health?

At Wellvia, we believe the objective should be bigger than weight loss alone.

The goal is to lose excess fat while protecting muscle, strength, nutritional health and physical capability.

1. Less hunger does not mean fewer nutritional needs

GLP-1-based medications alter appetite and food intake. This can make it easier for someone to eat less, but it can also make it harder to consume enough protein, fibre, essential fats, vitamins and minerals.

Women taking these medications should not assume that eating as little as possible will deliver the best outcome.

During substantial weight loss, some lean tissue may be lost alongside fat. Preserving muscle matters because muscle supports strength, movement, glucose regulation and independence throughout life.

The solution is not simply to add a protein shake. It is to build a nutritional strategy around the individual.

That means considering body composition, training, dietary preferences, medical history, appetite, medication tolerance and the rate of weight loss.

2. Strength training is not optional in a well-designed plan

Cardio has a role in cardiovascular health, fitness and energy expenditure. But walking, cycling and running should not replace resistance training.

A structured strength programme helps maintain the stimulus needed to preserve muscle while body weight decreases.

For many women, a sensible starting point is two or three resistance-training sessions each week, adjusted for experience, recovery and medical circumstances. Training should include the major movement patterns: squatting, hinging, pushing, pulling, carrying and balance.

Progress should be measured through more than weight loss. Can you maintain your strength? Are everyday tasks becoming easier? Is your fitness improving? Are you retaining muscle as your body composition changes?

These are meaningful measures of progress.

3. Women are not simply smaller versions of men

Women’s health requires additional context. Menstrual bleeding, hormonal contraception, pregnancy considerations, perimenopause and menopause can all influence how a personalised programme should be designed.

However, we should be careful not to replace one oversimplification with another.

The evidence does not justify prescribing a completely different workout for every phase of every woman’s menstrual cycle. Some women notice substantial changes in energy, sleep, hunger, pain or perceived exertion; others notice very little.

The practical approach is to track the individual and respond to what actually happens.

During menstruation

If cramps, heavy bleeding or fatigue affect training, reducing the session’s volume or intensity may be appropriate. If symptoms are mild and energy is normal, there is no automatic reason to stop strength training.

Heavy periods and persistent fatigue deserve attention. Iron deficiency is one possible explanation and should be assessed clinically rather than assumed.

During the rest of the cycle

Continue progressing training when performance and recovery support it. Around ovulation or during the luteal phase, there is no universal requirement to train harder, eat a prescribed set of additional calories or avoid heavy lifting.

If premenstrual symptoms affect sleep, appetite, temperature tolerance or exercise performance, adjust the programme accordingly.

During perimenopause and menopause

The focus on resistance training, adequate nutrition, muscle function and bone health becomes particularly important. Menstrual-cycle-based programming may no longer be appropriate when cycles are irregular or have ceased.

Individual assessment matters more than a generic hormonal calendar.

4. Eat for the body you want to preserve

When appetite is suppressed, food quality and meal planning become especially important.

Protein: A practical starting range for many adults undergoing weight loss is approximately 1.2–1.6 grams per kilogram of body weight per day, although the appropriate target depends on body composition, overall energy intake, kidney health and other individual factors.

Carbohydrates: Oats, potatoes, rice, fruit and wholegrains can support training and recovery. Eliminating carbohydrates is not a requirement of GLP-1 treatment.

Dietary fats: Include appropriate sources of essential fats and avoid unnecessarily restrictive diets.

Fibre and micronutrients: Maintain dietary variety through vegetables, fruit, legumes and other tolerated foods. Women with limited food intake, heavy menstrual bleeding or symptoms suggesting deficiency may need clinical assessment.

Hydration: Nausea, vomiting and diarrhoea can make hydration more difficult. Persistent symptoms require medical advice.

Small, manageable meals can help when appetite is low. The priority is not to force large portions, but to make the food that is eaten nutritionally worthwhile.

5. Monitor the quality of weight loss

A falling scale weight is only one data point.

A more complete assessment may include waist circumference, body composition, strength, physical function, energy levels, nutritional adequacy and menstrual health.

Body-composition measurements also have limitations and should be interpreted alongside other measures rather than treated as perfectly precise.

A woman whose weight is falling but whose strength, energy and ability to function are deteriorating needs a review of the plan—not congratulations for losing weight faster.

New menstrual irregularity or loss of periods during substantial weight loss should not simply be dismissed as a normal side effect of dieting. It warrants appropriate medical assessment.

6. Think beyond the medication

Medication may be part of a longer-term treatment strategy for obesity. It should not be treated as a substitute for building sustainable habits, and it should never be stopped or adjusted without appropriate clinical guidance.

Nutrition, exercise, sleep, stress management and behavioural support remain important during treatment and when treatment changes.

The most effective plan is one that the individual can maintain, that protects health and function, and that responds to changes in physiology rather than following a generic template.

The Wellvia perspective

We believe that better health comes from understanding the individual, not simply treating a number.

For women using weight-loss medication, this means looking beyond appetite and body weight to the factors that influence long-term outcomes: muscle, nutrition, menstrual health, bone health, physical performance and recovery.

The right programme should evolve as the individual changes.

Lose fat. Protect muscle. Respect your biology. Build health that lasts.

Clinical note: This article is for general educational purposes and is not a substitute for medical assessment or individualised prescribing advice. Weight-loss medication should be used under appropriate clinical supervision. Recommendations for training and nutrition should be tailored to each person’s health, medication, nutritional status and capacity.

Evidence and further reading

• UK Medicines and Healthcare products Regulatory Agency (MHRA), GLP-1 medicines for weight loss and diabetes: what you need to know.

• British Nutrition Foundation, Weight loss medications and nutrition.

• American Diabetes Association, Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity.

• Consensus guidance on menstrual-cycle considerations in exercise: current evidence supports individualised adjustments for symptoms rather than universal phase-based prescriptions.